Investor Material
Webcasts
Video
Corporate Publications
WEBCASTS
Anavex Life Sciences Presents at the H. C. Wainwright Global Investment Conference 2022
Anavex Life Sciences Reports Second Quarter Financials and Business Outlook 2022
Annual Needham Virtual Neuroscience Forum 2022
Anavex Life Sciences Reports First Quarter Financials and Business Outlook 2022
ANAVEX®2-73 AVATAR Phase 3 Trial met Primary and Secondary Efficacy Endpoints
2nd Annual Mitochondria-Targeted Drug Development - February 24, 2022
ANAVEX®3-71 Phase 1 Top Line Data Conference Call
40th Annual J.P. Morgan Healthcare Conference
4th Annual Evercore ISI HealthCONx Conference
Anavex Life Sciences Reports Fourth Quarter Financials and Business Outlook 2021
Anavex Life Sciences Reports Third Quarter Financials and Business Outlook 2021
Anavex Life Sciences Reports Second Quarter Financials and Business Outlook 2021
Anavex Life Sciences Reports First Quarter Financials and Business Outlook 2021
B. Riley Neuroscience Conference April 2021
VIDEO
Educational Video News Release: Broad SIGMAR1 Platform June 2022
Anavex Rett Syndrome Advocacy December 2020
CORPORATE PUBLICATION
Corporate Presentation September 2022
2021 Anavex Proxy Statement
Anavex Life Sciences Corp 10K
CTAD Presentation November 2020
Stay Connected
Follow us on social media
Events
Newsroom
Contact Us
Anavex Life Sciences to Present at the Guggenheim 4th Annual Immunology and Neurology Conference 2022
